October 2, 2026

Real Estate

Technology

An inside look at Latigo’s 2026 IPO

Latigo’s team is celebrating ringing the Nasdaq opening bell on the day it debuted. (courtesy photo) The Central Coast had gone years without a traditional initial public offering, but that streak broke when Thousand Oaks-based Latigo Biotherapuetics boosted the biotech scene of the Conejo Valley with a better-than-expected raise. Latigo, which specializes in developing non-opioid pain medicines, went public Aug. 6, debuting at a share price of $18. Shares closed Read More >

Newsmakers

Sponsored Content
Gregory Shamoon

J.P. Morgan Private Bank

Kyle Bobo

J.P. Morgan Private Bank

Jason Williams

Fifth Third Bank

Mack Carlson

Brownstein Hyatt Farber Schreck

ADVERTISING

Reach our audience with your message

Pacific Coast Business Times provides marketers with access to an affluent, educated business community of decision-makers via multimedia formats. Whichever media format or combination of media you choose, the Business Times helps you reach your marketing and sales goals.

Connect with our audience

94%

Answered the Business Times had influenced their buying decisions.

92%

Read the Pacific Coast Business Times for business news.

78%

Have obtained a four-year college degree.